Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology-Reference-Cited by-同舟云学术

Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology

Published:2017-11 Issue:4 Volume:33 Page:415-424
ISSN:0749-2081
Container-title:Seminars in Oncology Nursing
language:en
Short-container-title:Seminars in Oncology Nursing

Author:

Davis Mary Elizabeth,Francis Jasmine H.

Publisher

Elsevier BV

Subject

Oncology (nursing)

Reference48 articles.

1. How checkpoint inhibitors are changing the treatment paradigm in solid tumors: what advanced practitioners in oncology need to know;Davies;J Adv Pract Oncol,2016

2. Autoimmunity associated with immunotherapy of cancer;Amos;Blood,2011

3. New onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient;Miserocchi;Can J Ophthalmol,2015

4. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports;Abdel-Wahab;PLoS ONE,2016

5. Ipilimumab in the treatment of metastatic melanoma: management of adverse events;Della Vittoria Scarpati;Onco Targets Ther,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral Cystoid Macular Edema with Zanubrutinib Therapy: A Case Report;Case Reports in Oncology;2023-07-13

2. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review;Journal of Ophthalmic Inflammation and Infection;2023-02-22

3. Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab;Frontiers in Ophthalmology;2023-01-05

4. Neuro-ophthalmic manifestations of cancer: a narrative review;Chinese Clinical Oncology;2022-06

5. Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management;International Journal of Ophthalmology;2022-04-18